Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.46 |
| ▸ | MGMT | P16455 | 1/20 | 0.46 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.46 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 7/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.36 |
| ▸ | LMNA | P02545 | 6/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.36 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 2/20 | 0.36 |
| ▸ | CASP7 | P55210 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3850636 | 0.81 | NUDT1 (0.38) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL23037259 | 0.81 | NUDT1 (0.33) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL3854995 | 0.76 | NUDT1 (0.33) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL2800474 | 0.76 | NPC1 (0.57) | NUDT1MAPTALDH1A1POLBLMNA | |
| SCHEMBL3854998 | 0.73 | CDK1 (0.33) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL6398516 | 0.73 | THRB (0.44) | NUDT1ALDH1A1POLBKMT2AMAPK1 | |
| SCHEMBL3853468 | 0.72 | FGFR1 (0.30) | — | |
| SCHEMBL23037265 | 0.72 | CDK1 (0.47) | CDK1CCNB1MGMTCCNA2CDK2 | |
| SCHEMBL10398846 | 0.71 | CDK1 (0.43) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16463790 | 0.71 | CDK1 (0.43) | CDK1CCNB1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11603380-B2 | Antiviral acyclonucleoside analogues for use in treating a viral infection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-03-14 | — | — | US | disclosed |
| US-20210079031-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | NEOVIRTECH (FR) | 2021-03-18 | — | — | US | disclosed |
| US-20210079031-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | NEOVIRTECH (FR) | 2021-03-18 | — | — | US | disclosed |
| EP-3784680-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | Centre national de la recherche scientifique (FR) | 2021-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11603380-B2 | Antiviral acyclonucleoside analogues for use in treating a viral infection | TYMP, EIF2AK2, ENTPD5 | CDK1 621/4885CCNB1 825/4885MGMT 1720/4885 |
| US-20210079031-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | TYMP, EIF2AK2, PNP | CDK1 256/4885CCNB1 485/4885MGMT 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.